SEC Form 4 · accession 0001140361-17-007725
BioRestorative Therapies, Inc. · BRTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Edward L. Field
Officer — President brtxDISC Division
Period of report
Feb 14, 2017
Accepted (ET)
Feb 15, 2017 · 4:41 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001505497
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| OptionF4,F1 | $9.20 | Feb 14, 2017 | D | 25,000 | D | — | Feb 9, 2025 | Common Stock | 25,000 | 0 | D |
| OptionF4,F1 | $4.70 | Feb 14, 2017 | A | 25,000 | A | — | Feb 9, 2025 | Common Stock | 25,000 | 25,000 | D |
| OptionF4,F2 | $7.00 | Feb 14, 2017 | D | 25,000 | D | — | Sep 4, 2025 | Common Stock | 25,000 | 0 | D |
| OptionF4,F2 | $4.70 | Feb 14, 2017 | A | 25,000 | A | — | Sep 4, 2025 | Common Stock | 25,000 | 25,000 | D |
| OptionF3 | $3.73 | holding | — | — | — | — | Jun 10, 2026 | Common Stock | 80,000 | 80,000 | D |
Explanation of responses
- F1The option vests to the extent of 8,334 shares on February 9, 2016 and 8,333 shares on each of February 9, 2017 and February 9, 2018.
- F2The option is exercisable to the extent of 8,334 shares on September 4, 2016 and 8,333 shares on each of September 4, 2017 and September 4, 2018.
- F3The option is exercisable to the extent of 26,667 shares on each of June 10, 2017 and June 10, 2018, and 26,666 shares on June 10, 2019.
- F4The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price.